首页> 外文期刊>European journal of internal medicine >The antiphospholipid (Hughes') syndrome: changing the face of neurology.
【24h】

The antiphospholipid (Hughes') syndrome: changing the face of neurology.

机译:抗磷脂(休斯氏)综合征:改变神经病学的面貌。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Hughes' syndrome (the antiphospholipid syndrome (APS)) presents with recurrent thrombosis, recurrent miscarriage and neurological disease. The major pathogenic mechanism of the syndrome is vascular obstruction (both venous and arterial) due to hypercoagulability. Neurological manifestations are prominent and are often the dominant feature. Headache, migraine and cognitive dysfunction are common while other manifestations such as dementia, epilepsy, chorea, multiple sclerosis (MS), psychiatric disease, transverse myelitis, ocular syndromes, sensorineural hearing loss and movement disorders are also associated with the syndrome. Anticoagulation therapy (either aspirin or oral anticoagulants) can lead to significant improvement.
机译:休斯综合症(抗磷脂综合症(APS))表现为复发性血栓形成,反复流产和神经系统疾病。该综合征的主要致病机制是由于高凝性引起的血管阻塞(静脉和动脉)。神经学表现突出并且通常是主要特征。头痛,偏头痛和认知功能障碍很常见,而其他表现如痴呆,癫痫,舞蹈症,多发性硬化症(MS),精神病,横贯性脊髓炎,眼部综合征,感觉神经性听力减退和运动障碍也与该综合征相关。抗凝疗法(阿司匹林或口服抗凝药)可导致显着改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号